AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 100 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $851,181 | -43.9% | 133,414 | -2.6% | 0.11% | -44.2% |
Q2 2023 | $1,518,310 | -28.5% | 136,908 | -1.1% | 0.20% | -32.5% |
Q1 2023 | $2,124,747 | -30.8% | 138,420 | 0.0% | 0.29% | -35.0% |
Q4 2022 | $3,071,540 | -12.8% | 138,420 | -35.8% | 0.45% | -30.9% |
Q3 2022 | $3,523,000 | +12.4% | 215,750 | 0.0% | 0.65% | -17.5% |
Q2 2022 | $3,134,000 | -98.5% | 215,750 | -94.6% | 0.79% | -73.6% |
Q1 2022 | $215,750,000 | +4107.3% | 3,984,902 | +1747.0% | 2.99% | +108.4% |
Q4 2021 | $5,128,000 | -9.3% | 215,750 | -6.0% | 1.43% | -10.1% |
Q3 2021 | $5,654,000 | -0.3% | 229,595 | 0.0% | 1.59% | -14.6% |
Q2 2021 | $5,673,000 | -36.6% | 229,595 | -44.0% | 1.87% | -43.1% |
Q1 2021 | $8,946,000 | -33.1% | 410,181 | -21.8% | 3.28% | -33.0% |
Q4 2020 | $13,378,000 | – | 524,239 | – | 4.90% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |